Hydroxystilbamidine isethionate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydroxystilbamidine isethionate and what is the scope of patent protection?
Hydroxystilbamidine isethionate
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for hydroxystilbamidine isethionate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Patent Applications: | 55 |
| DailyMed Link: | hydroxystilbamidine isethionate at DailyMed |
US Patents and Regulatory Information for hydroxystilbamidine isethionate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | HYDROXYSTILBAMIDINE ISETHIONATE | hydroxystilbamidine isethionate | INJECTABLE;INJECTION | 009166-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
